4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-106431
CIK 0001660719operating
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:00 PM ET
Size
7.1 KB
Accession
0001104659-16-106431
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Award
Stock Options (right to buy)
2016-03-17+38,559→ 38,559 totalExercise: $3.80Exp: 2026-03-17→ Common Shares, without par value (38,559 underlying) - Award
Common Shares, without par value
2016-03-17+45,553→ 161,553 total
Footnotes (2)
- [F1]Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Long-Term Incentive Plan, which vest ratably over three years commencing on the anniversary of the date-of-grant.
- [F2]The options vest in equal tranches on a monthly basis over a 4-year period beginning on April, 17, 2016.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:00 PM ET
- Size
- 7.1 KB